BibSonomy bookmarks for /user/avivagabriel/plaquehttps://www.bibsonomy.org/user/avivagabriel/plaqueBibSonomy RSS Feed for /user/avivagabriel/plaqueAtherosclerosis and Inflammation of the Cardiovascular System =.= National Institutes of Health (NIH)http://cms.csr.nih.gov/PeerReviewMeetings/CSRIRGDescription/CVSIRG/AICS.htmavivagabriel2007-08-07T01:15:49+02:00NOS ROS T-cell artery atherosclerosis cardiology cardiovascular cell chemokines coronary cytokines endothelial endothelium immune inflammation inflammatory interleukin macrophages nitrogen oxygen plaque reactive receptors signaling species vascular vessel <a itemprop="url" data-versiondate="2007-08-07T01:15:49+02:00" href="http://cms.csr.nih.gov/PeerReviewMeetings/CSRIRGDescription/CVSIRG/AICS.htm" rel="nofollow" class="description-link">http://cms.csr.nih.gov/PeerReviewMeetings/CSRIRGDescription/CVSIRG/AICS.htm</a>Endothelial Vulnerability or Dysfunction =.= Characteristics of the Injurious Agenthttp://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=athero.section.97avivagabriel2007-08-06T22:29:20+02:00atherosclerosis cardiology cardiovascular coronary cytokines endothelial endothelium inflammation inflammatory medical medicine plaque textbook <a itemprop="url" data-versiondate="2007-08-06T22:29:20+02:00" href="http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=athero.section.97" rel="nofollow" class="description-link">http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=athero.section.97</a>Inflammation Inhibitor (DG-031) May Limit Risk for Heart Attackscientists reported that a person's risk of a heart attack is doubled if he or she produces a particular version of FLAP, known more technically as 5-lipoxygenase activating protein. A troublesome variant of this protein boosts production of the inflammathttp://findarticles.com/p/articles/mi_m1200/is_23_167/ai_n14791480/printavivagabriel2007-08-06T04:44:41+02:005-lipoxygenase FLAP attacks chronic cytokines drug genes heart inflammation inflammatory inhibitor interleukins leukotriene pathophysiology pharmaceutical plaque <span itemprop="description">scientists reported that a person's risk of a heart attack is doubled if he or she produces a particular version of FLAP, known more technically as 5-lipoxygenase activating protein. A troublesome variant of this protein boosts production of the inflammat</span>A Little Angina May Actually Be GOOD for You!Wellcome Trust, UK.http://www.wellcome.ac.uk/doc_wtx023674.htmlavivagabriel2007-08-04T02:03:40+02:00angina artery atherosclerosis cardiology cardiovascular coronary disease hypoxia infarct ischemia ischemic_preconditioning medicine myocardial plaque preconditioning <span itemprop="description">Wellcome Trust, UK.</span>Beta-Blockers May Exert Anti-Atherosclerotic Effects - Breaking Medical News CME Teaching Brief® - MedPage Todayhttp://www.medpagetoday.com/Cardiology/CoronaryArteryDisease/dh/6078avivagabriel2007-08-03T09:40:19+02:00arteries atherosclerosis betablockers cardiology cardiovascular coronary medicine plaque <a itemprop="url" data-versiondate="2007-08-03T09:40:19+02:00" href="http://www.medpagetoday.com/Cardiology/CoronaryArteryDisease/dh/6078" rel="nofollow" class="description-link">http://www.medpagetoday.com/Cardiology/CoronaryArteryDisease/dh/6078</a>ScienceDaily: Two Drugs May Stabilize Plaques In Atherosclerosishttp://www.sciencedaily.com/releases/2006/11/061112094524.htmavivagabriel2007-08-03T08:55:15+02:00artery atherosclerosis cardiology coronary drugs medications medicine plaque <a itemprop="url" data-versiondate="2007-08-03T08:55:15+02:00" href="http://www.sciencedaily.com/releases/2006/11/061112094524.htm" rel="nofollow" class="description-link">http://www.sciencedaily.com/releases/2006/11/061112094524.htm</a>Differential Signaling for MCP-1-Dependent Integrin Activation and ChemotaxisDr. Noboru Ashida, Department of Geriatric Medicine, Graduate School of Medicine, Kyoto University, 54 Kawaramachi, Shogoin Sakyo-ku, Kyoto 606-8507, Japan. Voice +81-75-751-3465; fax: +81-75-751-3574; ash@kuhp.kyoto.u.ac.jp.http://www.blackwell-synergy.com/doi/abs/10.1111/j.1749-6632.2001.tb03969.xavivagabriel2007-07-27T22:56:01+02:00artery atherosclerosis cardiology cardiovascular chemotaxis coronary cytokines inflammation inflammatory integrin kinase medicine mitogen-activated occlusion p38 p38-MAPK plaque protein <span itemprop="description">Dr. Noboru Ashida, Department of Geriatric Medicine, Graduate School of Medicine, Kyoto University, 54 Kawaramachi, Shogoin Sakyo-ku, Kyoto 606-8507, Japan. Voice +81-75-751-3465; fax: +81-75-751-3574; ash@kuhp.kyoto.u.ac.jp.</span>ScienceDaily ~:> Beyond Lipids ~:> Understanding The Mechanics Of Atherosclerosishttp://www.sciencedaily.com/releases/2006/07/060721203545.htmavivagabriel2007-07-25T23:06:15+02:00JNK N-terminal actin artery atherosclerosis biochemical blood branches c-jun cardiology cardiovascular cells cellular coronary disease fibers forces inflammation inflammatory kinase mechanical medicine occlusions plaque proteins shear structural vessels <a itemprop="url" data-versiondate="2007-07-25T23:06:15+02:00" href="http://www.sciencedaily.com/releases/2006/07/060721203545.htm" rel="nofollow" class="description-link">http://www.sciencedaily.com/releases/2006/07/060721203545.htm</a>Pleiotropic Effects of Statins =::= Not Just Lipid-Lowering =::= Annual Review of Pharmacology and ToxicologyPleiotropic effects of statins: improving endothelial function, enhancing stability of atherosclerotic plaques, decreasing oxidative stress & inflammation, inhibiting thrombogenic response, & beneficial extrahepatic effects on the immune system, CNS, andhttp://arjournals.annualreviews.org/doi/abs/10.1146/annurev.pharmtox.45.120403.095748avivagabriel2007-07-20T10:13:22+02:00CNS angina antiinflammatory artery atherosclerosis biomarker bone c-reactive-protein cardiology cardiovascular coronary disease endothelial immune immunity immunomodulatory infarction inflammation inflammatory ischemia levels lipid lipids marker medicine myocardial normal oxidative plaque pleiotropic stress thrombosis <span itemprop="description">Pleiotropic effects of statins: improving endothelial function, enhancing stability of atherosclerotic plaques, decreasing oxidative stress & inflammation, inhibiting thrombogenic response, & beneficial extrahepatic effects on the immune system, CNS, and</span>JAMA =::= Abstract: Antiatherothrombotic Properties of Statins ~ Implications for Cardiovascular Event Reduction =::= Rosenson and TangneyStatins have nonlipid mechanisms that modify endothelial function, inflammatory responses, plaque stability, and thrombus formation. Benefits extend to patients with normal lipid levels due to statins' pleiotropic effects.http://jama.ama-assn.org/cgi/content/abstract/279/20/1643?ijkey=d56732d60e0fb70be4d83e2a7295b8c812acefe3&keytype2=tf_ipsecshaavivagabriel2007-07-20T09:37:50+02:00endothelial inflammation inflammatory levels lipid normal plaque pleiotropic stability statin thrombosis <span itemprop="description">Statins have nonlipid mechanisms that modify endothelial function, inflammatory responses, plaque stability, and thrombus formation. Benefits extend to patients with normal lipid levels due to statins' pleiotropic effects.</span>